Form D/A — Endogenex, Inc.
0001730881-26-000004 · filed Nov 6, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Other Health Care filings
Offering
- Industry
- Other Health Care
- Exemptions
- 06b
- Reported offering amount
- $144,555,034
- Reported amount sold
- $132,351,879
- Minimum investment
- $0
- Investors
- 16
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Endogenex, Inc.
- CIK
- 1730881
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 13755 1st Ave North, #100
PLYMOUTH, MN 55441 - Phone
- 6513413805
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Stacey Pugh · Executive OfficerPlymouth, MN Find on LinkedIn ↗
-
Juliet Bakker · DirectorPlymouth, MN Find on LinkedIn ↗
-
Gerald Brunk · DirectorPlymouth, MN Find on LinkedIn ↗
-
James Eadie · DirectorPlymouth, MN Find on LinkedIn ↗
-
Doug Reed · DirectorPlymouth, MN Find on LinkedIn ↗
-
Thomas Shehab · DirectorPlymouth, MN Find on LinkedIn ↗
-
Krissy Wright · Executive OfficerPlymouth, MN Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗